Elevance Health: An Insight Into Medicaid and ACA Market Developments & Key Growth Levers! 

Elevance Health’s second-quarter earnings reveal a complex landscape marked by both opportunities and challenges. The company reported GAAP diluted earnings per share of $7.72 and adjusted diluted earnings per share of $8.84. Despite delivering adjusted EPS consistent with expectations, Elevance revised its full-year 2025 adjusted EPS guidance to approximately $30, reflecting industry-wide pressures, including elevated medical costs in the ACA market and slower-than-expected Medicaid rate alignments. The revision underscores challenges but also reflects strategic adjustments to enhance long-term sustainability.